| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00253-008-1579-Y |
| P698 | PubMed publication ID | 18607587 |
| P2093 | author name string | Jaspal K Kumar | |
| P2860 | cites work | High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme | Q39856762 |
| Aspects of the epidemiology of bovine staphylococcal mastitis | Q40582472 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 555-561 | |
| P577 | publication date | 2008-07-08 | |
| P1433 | published in | Applied Microbiology and Biotechnology | Q13553694 |
| P1476 | title | Lysostaphin: an antistaphylococcal agent | |
| P478 | volume | 80 |
| Q46447298 | 1H, 13C and 15N resonance assignments of the new lysostaphin family endopeptidase catalytic domain from Staphylococcus aureus |
| Q39156408 | A proteomics workflow for quantitative and time-resolved analysis of adaptation reactions of internalized bacteria |
| Q38787366 | A review of the recent advances in antimicrobial coatings for urinary catheters. |
| Q34294373 | Anti-staphylococcal activities of lysostaphin and LytM catalytic domain |
| Q41993542 | Antibiofilm agents: A new perspective for antimicrobial strategy |
| Q33579524 | Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B. |
| Q38071062 | Antimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms |
| Q34206850 | Antistaphylococcal activity of bacteriophage derived chimeric protein P128 |
| Q41465809 | Bacillus subtilis CwlP of the SP-{beta} prophage has two novel peptidoglycan hydrolase domains, muramidase and cross-linkage digesting DD-endopeptidase |
| Q83396229 | Bactericidal synergy of lysostaphin in combination with antimicrobial peptides |
| Q37755985 | Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic. |
| Q36342088 | Beyond growth: novel functions for bacterial cell wall hydrolases |
| Q38702083 | Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity |
| Q57657398 | Cell wall active antibiotics reduce chromosomal DNA fragmentation by peptidoglycan hydrolysis in Staphylococcus aureus |
| Q86910876 | Cell wall-affecting antibiotics modulate natural transformation in SigH-expressing Staphylococcus aureus |
| Q44488180 | Characterization of the staphylococcal bacteriophage lysin CHAP(K). |
| Q41831638 | Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans. |
| Q51740491 | Clostridium difficile secreted Pro-Pro endopeptidase PPEP-1 (ZMP1/CD2830) modulates adhesion through cleavage of the collagen binding protein CD2831. |
| Q36309151 | Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Förster resonance energy transfer (FRET) assays |
| Q28391444 | Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection |
| Q36994350 | Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin |
| Q41457130 | EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis |
| Q34394175 | Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection |
| Q34226868 | EnzyBase: a novel database for enzybiotic studies |
| Q37918447 | Extracellular metalloproteases from bacteria |
| Q54212204 | Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing. |
| Q39766508 | Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains |
| Q36911438 | In Vitro and in Vivo Antistaphylococcal Activity Determination of the New Recombinant Lysostaphin Protein |
| Q38282871 | In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin |
| Q47096972 | In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus |
| Q33798586 | Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics |
| Q35599270 | Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium |
| Q42411103 | Inhibition of the Activity of Both Domains of Lysostaphin through Peptidoglycan Modification by the Lysostaphin Immunity Protein |
| Q28391136 | Intra-cellular Staphylococcus aureus alone causes infection in vivo |
| Q28257999 | Intracellular detection and evolution of site-specific proteases using a genetic selection system |
| Q33659336 | Laser desorption postionization mass spectrometry of antibiotic-treated bacterial biofilms using tunable vacuum ultraviolet radiation. |
| Q90426445 | Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model |
| Q64052826 | Lysostaphin and BMP-2 co-delivery reduces infection and regenerates critical-sized segmental bone defects |
| Q34764770 | Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model |
| Q33664443 | Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications |
| Q43091002 | Methods to identify enzymes that degrade the main extracellular polysaccharide component of Staphylococcus epidermidis biofilms |
| Q90473947 | Nonconventional Therapeutics against Staphylococcus aureus |
| Q40995303 | Orthopedic implant infections: Incompetence of Staphylococcus epidermidis, Staphylococcus lugdunensis, and Enterococcus faecalis to invade osteoblasts. |
| Q34566563 | Potential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation. |
| Q34012319 | Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia |
| Q90294069 | Remodeling of Cross-bridges Controls Peptidoglycan Cross-linking Levels in Bacterial Cell Walls |
| Q39174819 | Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus. |
| Q48171161 | Sodium Polyanethol Sulfonate Modulates Natural Transformation of SigH-Expressing Staphylococcus aureus |
| Q38998331 | Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides. |
| Q57177389 | Unprotonated Short-Chain Alkylamines Inhibit Staphylolytic Activity of Lysostaphin in a Wall Teichoic Acid-Dependent Manner |
Search more.